Phase 1 Type 1 Diabetes Trial, Recruiting (NCT05065372)

Phase 1 Type 1 Diabetes Trial, Recruiting NCT05065372 Sponsor: Kalie Tommerdahl Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT05065372 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have Type 1 diabetes and have been using an automated insulin delivery system, or multiple daily insulin injections/insulin pump together with a continuous glucose monitor, for more than 6 months
You are between 12 and 25 years old
Your most recent HbA1c blood sugar average test result is below 11%
You have not had a serious diabetes-related emergency (such as diabetic ketoacidosis or a dangerous high blood sugar crisis) in the last 30 days
You have gone through the start of puberty (confirm with trial site)
You weigh more than 54 kg (about 119 lbs) and your BMI is above the 5th percentile for your age and sex

Who may not be able to join:

Your blood pressure is higher than 140/90 mmHg
Your hemoglobin (a measure of red blood cells) is below 9 g/dL, which may indicate anaemia
You have signs of reduced kidney function, a history of significant protein in your urine, or a history of sudden kidney injury (confirm with trial site)
You take any diabetes medications other than insulin, or regularly take certain other medications including ACE inhibitors, ARBs, diuretics, daily anti-inflammatory painkillers (like ibuprofen), aspirin, or certain other specific drugs (confirm with trial site)
You have an allergy to seafood or iodine
You are currently pregnant or breastfeeding (applies to females)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05065372

Sponsor: Kalie Tommerdahl

Phase: Phase 1

Status: Recruiting

Condition: Type 1 Diabetes

More information: https://clinicaltrials.gov/study/NCT05065372

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have Type 1 diabetes and have been using an automated insulin delivery system, or multiple daily insulin injections/insulin pump together with a continuous glucose monitor, for more than 6 months
You are between 12 and 25 years old
Your most recent HbA1c blood sugar average test result is below 11%
You have not had a serious diabetes-related emergency (such as diabetic ketoacidosis or a dangerous high blood sugar crisis) in the last 30 days
You have gone through the start of puberty (confirm with trial site)
You weigh more than 54 kg (about 119 lbs) and your BMI is above the 5th percentile for your age and sex

Who may not be able to join:

Your blood pressure is higher than 140/90 mmHg
Your hemoglobin (a measure of red blood cells) is below 9 g/dL, which may indicate anaemia
You have signs of reduced kidney function, a history of significant protein in your urine, or a history of sudden kidney injury (confirm with trial site)
You take any diabetes medications other than insulin, or regularly take certain other medications including ACE inhibitors, ARBs, diuretics, daily anti-inflammatory painkillers (like ibuprofen), aspirin, or certain other specific drugs (confirm with trial site)
You have an allergy to seafood or iodine
You are currently pregnant or breastfeeding (applies to females)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Kalie Tommerdahl

Registry

ClinicalTrials.gov

Start date

1 July 2022

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Renal vascular resistance; Glomerular filtration rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov